Scott R. Ward has bought stock on 6 days since Jan 2016

Scott R. Ward

Scott R. Ward is an accomplished healthcare executive with over 40 years of experience in the medical technology sector, including nearly 30 years at Medtronic, Inc., where he held senior leadership roles such as Senior Vice President and President of the CardioVascular, Neurological, and Diabetes businesses.( He served as Chairman, President, and CEO of Cardiovascular Systems, Inc. from 2015 to 2023 until its acquisition by Abbott, and previously held positions like Chairman at Surmodics, Inc. and MAP Pharmaceuticals.( Ward is the founder of Creganna Medical Pte Ltd. (1979) and Raymond Holdings, Inc. (2011), where he acts as Managing Director and CEO, respectively, focusing on venture capital and advisory services for medtech and life sciences.(

Currently, Ward serves as an Independent Director at InspireMD, Inc. (appointed 2024-11-24), where he owns approximately 237,096 shares valued at over $273,846 as of recent filings.( His other active roles include Director at Endologix LLC (since 2024), Chairman at CathWorks Ltd., and Managing Director at SightLine Opportunity Management II LLC.( He recently joined Evident Vascular's Board of Directors.( Ward holds a BS in Genetics and Cell Biology, MS in Toxicology, and MBA from the University of Minnesota.(

Written by Perplexity from public sources.